Results 51 to 60 of about 38,867 (216)

The optimal treatment of multivessel coronary artery disease [PDF]

, 2014
The practice of percutaneous coronary intervention has overtaken coronary bypass surgery in the treatment of ischaemic heart disease. Several randomized controlled as well as registry and observational trials have addressed the issue of patient selection
Manche, Alexander
core  

Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis - Tissue characteristics compared to primary atherosclerosis [PDF]

, 2004
Pathogenic events leading to in-stent restenosis (ISR) are still incompletely understood. Among others, inflammation, immune reactions, deregulated cell death and growth have been suggested. Therefore, atherectomy probes from 21 patients with symptomatic
Abdelmegui AE, Alexander Jabs, Bauriedel G, Bauriedel G, Berndt Lüderitz, Carter AJ, Chiu B, Dirk Skowasch, Epstein SE, Farb A, Gerhard Bauriedel, Kearney M, Kol A, Komatsu R, Mayr M, Moreno PR, Neumann FJ, Nicolas Wernert, O'Brien ER, Pickering JG, René Andrié, Sabine Dinkelbach, Simonton CA, Thomas M. Schiele, Zohlnhofer D   +24 more
core   +1 more source

Management of Lost Atherectomy Devices in the Coronary Arteries

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Rotational and orbital atherectomy are important tools to treat calcific coronary disease. Entrapment of an atherectomy device, that is, rotational atherectomy burr or orbital atherectomy crown, is a serious complication during atherectomy. Loss of an atherectomy device is a more challenging complication that usually follows device entrapment.
Gregor Leibundgut, Alexandru Achim, Daniel Weilenmann, Johannes Rigger, Fabian Gocht, Mohaned Egred, Bilal Murad, William Lombardi, M. Bilal Iqbal   +8 more
wiley   +1 more source

Intraaortic balloon pump support during coronary angioplasty. Initial experience

Arquivos Brasileiros de Cardiologia, 1999
OBJECTIVE: To evaluate the use of the intraaortic balloon (IAoB) in association with coronary angioplasty in high-risk patients. METHODS: Fourteen high-risk patients unresponsive to clinical therapy and with formal contraindication to surgical ...
Evandro C.V. Osterne, Gustavo A. Alexim, Vicente P. da Motta, Rosaly M.M. Lins, Eustáquio F. Carvalho, Marcos V. Carneiro, Elio Ribeiro de Morais, Alexandre V. Brick   +7 more
doaj   +1 more source

An analysis of published cases of cutting balloon use in spontaneous coronary artery dissection

Frontiers in Cardiovascular Medicine, 2023
IntroductionSCAD involves a sudden tear or separation within the layers of the coronary artery wall, resulting in blood flow obstruction and subsequent myocardial ischemia.Materials and methodsA comprehensive literature search was conducted to identify ...
Bojan Maričić, Zoran Perišić, Zoran Perišić, Tomislav Kostić, Tomislav Kostić, Nenad Božinović, Nenad Božinović, Milovan Petrović, Milovan Petrović, Milenko Čanković, Milenko Čanković, Zlatko Mehmedbegović, Zlatko Mehmedbegović, Stefan Juričić, Vladimir Vasilev, Sonja Dakić, Sonja Dakić, Jelena Perišić, Jelena Milošević, Mihajlo Bojanović, Miroslav Nikolić, Tijana Maričić, Svetlana Apostolović, Svetlana Apostolović   +23 more
doaj   +1 more source

Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan, Himanshu Rai, Daniele Giacoppo, J. J. Coughlan, Rory Durand, Valeria Paradies, Róisín Colleran, Gavin J. Blake, Fernando Alfonso, Robert A. Byrne   +9 more
wiley   +1 more source

Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of de novo Chronic Total Occlusions

Frontiers in Cardiovascular Medicine, 2022
BackgroundThe safety and efficacy of drug-coated balloon (DCB) treatment for de novo coronary chronic total occlusion (CTO) remain uncertain. The aim of this study was to evaluate the outcomes of DCB only treatment for de novo CTO.MethodsIn this ...
Eun Jung Jun, Eun Jung Jun, Eun-Seok Shin, Eun-Seok Shin, Eu-Vin Teoh, Youngjune Bhak, Song Lin Yuan, Song Lin Yuan, Chong-Mow Chu, Scot Garg, Houng Bang Liew   +10 more
doaj   +1 more source

Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. [PDF]

, 2014
Successful revascularisation of chronic total occlusions (CTOs) remains one of the greatest challenges in the era of contemporary percutaneous coronary intervention (PCI).
Fairley, SL, Hanratty, C, Rana, O, Spratt, JC, Talwar, S, Walsh, S   +5 more
core   +1 more source

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley   +1 more source

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane, Yosuke Hata, Osamu Iida, Yasunori Ueda, Kuniyasu Ikeoka, Taku Toyoshima, Motoki Yasunaga, Hiroaki Nohara, Akito Kawamura, Sho Nakao, Yohei Sotomi, Yasushi Sakata   +11 more
wiley   +1 more source